Obstetric embolism

O15_OBSTET_EMBOL

cholesterol embolism: Blocking of a blood vessel by cholesterol-rich atheromatous deposits, generally occurring in the flow from a large artery to small arterial branches. It is also called arterial-arterial embolization or atheroembolism which may be spontaneous or iatrogenic. Patients with spontaneous atheroembolism often have painful, cyanotic digits of acute onset.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only females	293373
2. Check conditions None	293373
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — O88 Hospital discharge: ICD-9 — 673 Hospital discharge: ICD-8 — 673 Cause of death: ICD-10 — O88 Cause of death: ICD-9 — 673 Cause of death: ICD-8 — 673 2 out of 7 registries used, show all original rules.	49
4. Check minimum number of events None	49
5. Include endpoints None	49
6. Filter based on genotype QC (FinnGen only)	49

Control definitions (FinnGen only)

Control exclude: O15_COMPLIC_PUERP

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF5
Parent code in ICD-10: O85-O92
Name in latin: Embolia obstetrica

NAME	O15_OBSTET_EMBOL
CONTROL_EXCLUDE	O15_COMPLIC_PUERP
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	O88
HD_ICD_9	673
HD_ICD_8	673
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	O88
COD_ICD_9	673
COD_ICD_8	673
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Obstetric embolism based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	419	419	-
Only index persons	374	374	-
Unadjusted period prevalence (%)
Whole population	0.01	0.01	-
Only index persons	0.01	0.01	-
Median age at first event (years)
Whole population	-	30.90	-
Only index persons	-	30.37	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	49	49	-
Unadjusted period prevalence (%)	0.02	0.02	-
Median age at first event (years)	28.92	28.92	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(4034850)

4.92

1.99

7.2

6.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

4.15

1.76

3.6

1.8

176.0

203.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

0.00

1.41

0.0

2.1

—

(3022621) pH of Urine by Test strip

2.83

1.41

3.5

1.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.59

1.28

1.0

—

(40761536) Microorganisms panel - Urine sediment

0.00

1.21

0.0

3.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

2.53

1.12

6.8

2.3

—

(3025941) Bacteria identified in Stool by Culture

0.00

1.01

0.0

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.88

0.88

1.1

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2.06

0.88

1.0

1.3

—

(3000850) Epithelial cells [#/volume] in Urine

1.79

0.84

2.5

2.1

17.3

4.3

e6/l

0.47

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.79

0.83

1.6

1.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

0.00

0.81

0.0

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

467

0.43

0.78

12.2

10.4

24.8

24.3

u/l

0.09

451

(36304419) Bacteria [Presence] in Urine

112

1.64

0.76

2.8

2.6

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

187

1.56

0.73

4.7

4.1

—

(3032080) INR in Blood by Coagulation assay

141

1.57

0.71

18.2

4.2

1.8

1.1

inr

—

(4010399)

1.95

0.70

2.2

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.00

0.62

0.0

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

0.00

0.62

0.0

1.3

—

73.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

0.00

0.62

0.0

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

0.00

0.62

0.0

2.6

—

1.4

—

(1002224) Polysomnography panel

0.00

0.62

0.0

1.0

—

(3008898) HLA-B27 [Presence]

0.00

0.61

0.0

1.2

—

(1761868) Lipid panel - Serum or Plasma

165

0.64

0.60

1.9

2.7

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.55

0.57

1.6

1.8

—

(3048689) Calprotectin [Mass/mass] in Stool

1.55

0.57

3.3

2.2

197.2

123.1

ug/g

—

(3042936) Bacteria identified in Isolate by Culture

1.52

0.56

2.6

1.8

—

(36660697) Celiac disease serology panel - Serum

1.61

0.55

1.0

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

121

1.48

0.53

2.0

2.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1.55

0.51

1.4

1.5

363.9

538.4

pmol/l

1.83

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

169

1.42

0.51

1.9

2.0

97.7

100.2

pmol/l

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.57

0.50

11.3

7.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.50

0.48

1.7

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

104

0.62

0.45

10.3

5.9

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.62

0.44

1.2

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1.46

0.43

1.9

2.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

145

1.38

0.42

2.4

3.2

21.6

15.9

ng/l

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.42

0.0

1.1

—

0.0

—

(40768443) Skin Pathology biopsy report

0.00

0.42

0.0

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.42

0.0

1.1

—

0.0

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.42

0.0

1.1

—

0.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.42

0.0

1.1

—

0.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.42

0.0

1.1

—

36.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

0.00

0.42

0.0

1.4

—

(4094501)

0.00

0.42

0.0

1.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.42

0.0

1.1

—

3.6

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.41

0.0

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.41

0.0

1.1

—

10.6

—

(3009542) Hematocrit [Volume Fraction] of Blood

409

0.68

0.40

15.3

13.3

40.4

39.6

0.96

313

(40758558) Short blood count panel - Blood

109

1.40

0.39

5.9

9.6

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

253

0.76

0.34

6.8

6.6

11.8

9.8

umol/l

0.64

239

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

419

1.49

0.28

4.0

4.3

5.6

5.8

mmol/l

0.77

387

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

302

1.28

0.28

3.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1.33

0.28

1.3

1.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

106

1.31

0.26

3.6

3.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1.30

0.24

1.3

3.9

1.7

u/ml

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

146

1.25

0.23

3.9

2.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

127

1.26

0.23

2.2

1.7

1.2

1.3

mmol/l

0.74

105

(3006504) Eosinophils/100 leukocytes in Blood

196

1.22

0.22

4.4

5.7

3.2

2.6

0.69

178

(40768804) Tissue Pathology biopsy report

204

0.81

0.22

1.8

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

2.2

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.21

0.0

1.7

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.21

0.0

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

0.00

0.21

0.0

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

5.0

—

93.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.21

0.0

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

0.21

0.0

1.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

0.00

0.21

0.0

1.3

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

4.7

—

73.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

0.00

0.21

0.0

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.21

0.0

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

109

1.26

0.21

4.7

3.4

1.3

2.9

mg/mmol

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.28

0.21

2.0

1.8

—

(3015736) pH of Urine

173

0.81

0.21

3.6

3.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

0.00

0.21

0.0

2.4

—

25.5

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1.26

0.21

2.2

2.1

35.0

22.0

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

0.00

0.20

0.0

1.3

—

2.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

129

1.23

0.20

1.5

2.1

78.4

90.4

u/l

0.51

123

(40768797) Stomach Pathology biopsy report

0.69

0.18

1.0

1.2

—

(3013512) EKG study

119

0.80

0.18

2.6

3.1

—

(3018010) Neutrophils/100 leukocytes in Blood

199

1.19

0.18

4.4

5.8

54.3

56.0

0.26

181

(3026008) Bacteria identified in Urine by Culture

141

1.20

0.16

3.4

2.7

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

210

1.18

0.16

5.3

6.0

1.2

mmol/l

0.09

176

(3023368) Bacteria identified in Blood by Culture

0.80

0.15

2.6

3.8

—

(3003694) ABO and Rh group [Type] in Blood

113

1.20

0.15

1.6

1.4

—

(3002030) Lymphocytes/100 leukocytes in Blood

203

1.15

0.12

4.4

6.0

30.5

29.7

0.15

183

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

115

0.84

0.12

1.1

1.4

—

(3013707) Erythrocyte sedimentation rate by Westergren method

326

1.14

0.09

5.8

4.5

11.2

11.6

mm/h

0.09

294

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.08

0.09

1.2

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.07

0.08

1.4

1.5

—

(3026782) Osmolality of Urine

1.07

0.08

3.0

2.3

553.7

525.7

mosm/kgh2o

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1.10

0.08

1.4

1.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

404

0.95

0.07

10.8

12.1

87.6

83.5

ml/min/173m2

0.75

324

(3019069) Monocytes/100 leukocytes in Blood

198

1.11

0.07

4.8

6.2

7.6

8.4

0.51

180

(3041096) Erythrocytes [Presence] in Urine by Automated

121

0.88

0.06

3.5

3.4

—

(3031040) Bacteria [#/volume] in Urine by Automated count

289

1.10

0.06

4.5

3.9

—

54.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

170

0.91

0.05

4.5

3.6

—

(42870588) Differential panel, method unspecified - Blood

136

0.94

0.01

4.8

5.7

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

176

0.95

0.00

7.3

3.9

36.7

35.9

g/l

0.36

166

(3037467) Urinalysis macro (dipstick) panel - Urine

294

1.05

0.00

5.4

3.8

—

(3044889) 12 lead EKG panel

295

1.04

0.00

3.7

3.4

—

(3022096) Basophils/100 leukocytes in Blood

195

0.96

0.00

4.7

5.5

0.8

0.7

0.55

174

(3033658) Prothrombin time (PT) actual/Normal

102

0.98

0.00

5.2

3.5

88.3

97.7

—

102

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

29.9

—

(3045788) Cell count panel - Pleural fluid

0.00

0.0

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3044290) Cell count panel - Cerebral spinal fluid

0.00

0.0

1.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.2

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

0.0

1.2

—

32.8

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

0.0

1.3

—

31.6

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

0.0

1.8

—

4.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(4062490)

0.00

0.0

1.5

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

0.00

0.0

1.3

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.0

4.0

—

4.0

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.0

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.0

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

0.00

0.0

2.2

—

37.8

—

(3012441) Differential panel - Pleural fluid

0.00

0.0

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.0

4.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.00

0.0

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

0.0

1.9

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.3

—

(3021901) Oxygen saturation in Capillary blood

0.00

0.0

2.3

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

0.0

1.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.3

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

0.00

0.0

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

0.00

0.0

3.6

—

7.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

0.0

1.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.6

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.2

—

(3045424) Erythrocytes [Presence] in Urine

0.00

0.0

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.00

0.0

3.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

0.00

0.0

1.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.0

1.5

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.0

1.0

—

(3042631) Mycobacterium sp identified in Specimen

0.00

0.0

8.7

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

0.0

1.2

—

3.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.00

0.0

3.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

0.0

1.8

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

0.0

4.3

—

(40768795) Lymph node Pathology biopsy report

0.00

0.0

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.0

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.2

—

(3023419) Bacteria identified in Sputum by Culture

0.00

0.0

3.7

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

0.00

0.0

1.2

—

(3005570) Glucose [Moles/volume] in Urine

0.00

0.0

2.5

—

(1616796) Gas panel - Central venous blood

0.00

0.0

3.0

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.0

1.3

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

0.0

3.9

—

6.7

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.0

1.5

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

0.0

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

0.00

0.0

2.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.0

1.5

—

(3023410) Appearance of Cerebral spinal fluid

0.00

0.0

1.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

0.0

1.8

—

62.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

0.00

0.0

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

0.0

1.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.0

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

0.0

1.4

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.0

5.6

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.0

4.0

—

107.0

—

(3023420) DNA double strand Ab [Units/volume] in Serum

0.00

0.0

1.5

—

(3037756) Immunofixation for Serum or Plasma

0.00

0.0

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.3

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.00

0.0

1.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1.03

0.00

7.9

2.6

2.4

2.5

mmol/l

—

Mortality – FinRegistry

↥

Association

Association between endpoint O15_OBSTET_EMBOL and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have O15_OBSTET_EMBOL.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: O15_OBSTET_EMBOL – Obstetric embolism

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Obstetric embolism

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints